Bergen, Norway-based BerGenBio ASA appointed Rune Skeie as CFO.
Skeie was previously CFO of REMA Franchise Norge AS.
Skeie's experience in finance and corporate development will help BerGenBio as it advances its product pipeline, which includes bemcentinib, CEO Richard Godfrey said.
Bemcentinib is being studied in combination with other drugs for treating types of lung cancer, breast cancer and leukemia.
